252 related articles for article (PubMed ID: 16335916)
1. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
2. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
[TBL] [Abstract][Full Text] [Related]
3. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
4. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
Mbemba E; Benjouad A; Saffar L; Gattegno L
Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity.
Hesselgesser J; Liang M; Hoxie J; Greenberg M; Brass LF; Orsini MJ; Taub D; Horuk R
J Immunol; 1998 Jan; 160(2):877-83. PubMed ID: 9551924
[TBL] [Abstract][Full Text] [Related]
6. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.
Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA
Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280
[TBL] [Abstract][Full Text] [Related]
7. The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.
Luo Z; Zhou N; Luo J; Hall JW; Huang Z
Biochem Biophys Res Commun; 1999 Oct; 263(3):691-5. PubMed ID: 10512741
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
9. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
Kumar S; Choi WT; Dong CZ; Madani N; Tian S; Liu D; Wang Y; Pesavento J; Wang J; Fan X; Yuan J; Fritzsche WR; An J; Sodroski JG; Richman DD; Huang Z
Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
[TBL] [Abstract][Full Text] [Related]
10. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C
J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187
[TBL] [Abstract][Full Text] [Related]
11. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.
Zhou N; Luo Z; Luo J; Hall JW; Huang Z
Biochemistry; 2000 Apr; 39(13):3782-7. PubMed ID: 10736178
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
Hegde R; Borkow G; Berchanski A; Lapidot A
FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
[TBL] [Abstract][Full Text] [Related]
13. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
[TBL] [Abstract][Full Text] [Related]
14. Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein.
LiWang AC; Cao JJ; Zheng H; Lu Z; Peiper SC; LiWang PJ
Biochemistry; 1999 Jan; 38(1):442-53. PubMed ID: 9890927
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 envelope is a neutral antagonist to CXCR4 in T-cells.
Staudinger R; Wang X; Bandrés JC
Biochem Biophys Res Commun; 2001 Feb; 280(4):1003-7. PubMed ID: 11162626
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study.
Toth PT; Ren D; Miller RJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):8-17. PubMed ID: 15014135
[TBL] [Abstract][Full Text] [Related]
17. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection.
Nagasawa T; Tachibana K; Kishimoto T
Semin Immunol; 1998 Jun; 10(3):179-85. PubMed ID: 9653044
[TBL] [Abstract][Full Text] [Related]
18. SDF-1-induced activation of ERK enhances HIV-1 expression.
Montes M; Tagieva NE; Heveker N; Nahmias C; Baleux F; Trautmann A
Eur Cytokine Netw; 2000 Sep; 11(3):470-7. PubMed ID: 11022134
[TBL] [Abstract][Full Text] [Related]
19. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha.
Gozansky EK; Louis JM; Caffrey M; Clore GM
J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815
[TBL] [Abstract][Full Text] [Related]
20. Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines.
Zhou N; Luo Z; Luo J; Fan X; Cayabyab M; Hiraoka M; Liu D; Han X; Pesavento J; Dong CZ; Wang Y; An J; Kaji H; Sodroski JG; Huang Z
J Biol Chem; 2002 May; 277(20):17476-85. PubMed ID: 11880384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
